• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: Japan

Daiwa ETF TOPIX-17 Pharmaceutical

+ Add to Watchlist

1638:JP

13,870.0000 JPY 170.0000 1.24%

As of 02:00:00 ET on 04/17/2014.

Snapshot for Daiwa ETF TOPIX-17 Pharmaceutical (1638)

Open: 13,800.0000 High - Low: 13,870.0000 - 13,800.0000 Primary Exchange: Tokyo
Volume: 14 52-Week Range: 12,450.0000 - 15,480.0000 Beta vs TP17PHRM: 0.8982

ETF Chart for 1638

No chart data available.
  • 1638:JP 13,870.0000
  • 1D
  • 1M
  • 1Y
13,700.0000
Interactive 1638 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for 1638

Daiwa ETF TOPIX-17 PHARMACEUTICAL ETF is an exchange-traded fund incorporated i n Japan. The objective of the Fund is to provide investment results that c orrespond to the performance of the TOPIX-17 Pharmaceutical Index.

Inception Date: 2008-07-23 Telephone: -
Managers: -
Web Site: www.daiwa-am.co.jp

Fundamentals for 1638

NAV (on 2014-04-16) 13,816.0000
Assets (M) (on 2014-04-16) 390.0000
Shares out (M) 0.03
Market Cap (M) 391.52
% Premium -0.84
Average 52-Week % Premium -0.2613
Fund Leveraged N

Dividends for 1638

Dividend Type Distribution
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-01-16) 172.0000
Dividend Yield (ttm) 2.49%

Performance for 1638

1-Month -2.91% 1-Year -2.49%
3-Month -7.56% 3-Year +13.93%
Year To Date -6.48% 5-Year +9.37%
Expense Ratio 0.18

Top Fund Holdings for 1638

Filing Date: 03/31/2014
Name Position Value % of Total
Takeda Pharmaceutical Co Ltd 20,400 99,796,800 24.132%
Astellas Pharma Inc 62,500 76,500,000 18.498%
Otsuka Holdings Co Ltd 10,800 33,339,600 8.062%
Daiichi Sankyo Co Ltd 17,100 29,719,800 7.187%
Eisai Co Ltd 6,700 26,920,600 6.510%
Ono Pharmaceutical Co Ltd 2,500 22,350,000 5.404%
Shionogi & Co Ltd 8,500 16,260,500 3.932%
Chugai Pharmaceutical Co Ltd 5,400 14,229,000 3.441%
Taisho Pharmaceutical Holdings 1,300 10,803,000 2.612%
Santen Pharmaceutical Co Ltd 2,000 9,160,000 2.215%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil